Month: June 2021

MCLEAN, Va., June 03, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) Multifamily has extended to September 30, 2021 the deadline for requesting a new COVID-19 forbearance agreement for its Multifamily loans. The program was previously set to terminate June 30, 2021. The extension provides additional time for multifamily operators experiencing hardship as a result of the pandemic to request a new forbearance agreement, which includes renter protections such as a moratorium on evictions for non-payment of rent. Borrowers continuing to experience hardship may also request additional relief at the end of the initial forbearance period. “The extension of our forbearance program reflects Freddie Mac’s commitment to providing support to the multifamily market and renters who have been financially impacted by the pandemic,” said Debby...

Reed’s Inc.® Expands Distribution of Handcrafted Beverage Portfolio with Publix Super MarketsReed’s Inc.® (Nasdaq: REED), maker of the nation’s leading portfolio of handcrafted, all-natural beverages, today announces expanded distribution with Publix Super MarketsNORWALK, Conn., June 03, 2021 (GLOBE NEWSWIRE) — Reed’s Inc.® (Nasdaq: REED), maker of the nation’s leading portfolio of handcrafted, all-natural beverages, today announces expanded distribution with Publix Super Markets as the retailer begins to carry the company’s best-selling REALLY REAL Ginger Ale™ and flagship Extra Ginger Beer in new 12 oz. cans. Now available in over 1,100 Publix Super Markets across the Southeast region of the United States, the all-natural beverages from Reed’s®, America’s #1 ginger company, brings more better-for-you options...

Eurobio Scientific launches its COVID antigen self-test Paris, June 2, 2021 – 5:45 pm Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in specialty in vitro medical diagnostics, announces the launch of its new proprietary test EBS 1005, an antigen self-test developed to identify the presence of the SARS-CoV-2 coronavirus by simple nasal sampling. An easy to use proprietary antigen self-test The proprietary EBS 1005 test received today an exemption from the French health authority, ANSM, to be marketed until CE marking is obtained. It also received a similar waiver from German health authorities. The test is intended to be sold in boxes of 5 tests, directly by pharmacies or under government contracts. EBS 1005 includes 5 unit test kits, each including an instructions leaflet, a nasal swab to be inserted...

Joint stock company “Olainfarm”, unified registration number 40003007246, legal address: 5 Rūpnīcu Street 5, Olaine, LV 2114, hereinafter referred to as “the Company”, invites shareholders to get acquainted with the notification regarding procedure for the Extraordinary General meeting of shareholders of June 17, 2021, published on the website of the Company www.olainfarm.com, in the Official system of the Central Storage of Regulated Information: https://csri.investinfo.lv and on the website of joint stock company “NASDAQ Riga”: http://www.nasdaqbaltic.com. Number of meeting participants to present in person (at the premises of the company 5 Rūpnīcu Street, Olaine, Olaine county) is limited.1 To participate in person at the premises of the company, shareholders, their proxy and representatives are invited to indicate in the application...

Update on Fixed Income Investor Calls Reference is made to the stock exchange release dated 25 May 2021, regarding fixed income investor calls commencing on 31 May. BW Offshore has decided to not proceed with the issue of a NOK denominated senior unsecured green bond as the Company considers the terms offered as unsatisfactory in the current market. For further information, please contact:Ståle Andreassen, CFO, +65 97 27 86 47Anders S. Platou, Head of Corporate Finance, +47 99 50 47 40 IR@bwoffshore.com or www.bwoffshore.com About BW Offshore:BW Offshore engineers innovative floating production solutions. The Company has a fleet of 14 FPSOs with potential and ambition to grow. By leveraging four decades of offshore operations and project execution, the Company creates tailored offshore energy solutions for evolving markets world-wide....

DEVON, Pa., June 03, 2021 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting a poster today from 10:00 a.m. – 11:00 a.m. ET in poster session II at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting. A copy of the poster is available on the Zynerba corporate website at http://zynerba.com/publications/. The poster titled, “ZYN002 Cannabidiol Transdermal Gel: Efficacy and Safety Findings in Children and Adolescents With Autism Spectrum Disorder (ASD) and Related Disorders,” shows that Zygel™ may provide important clinical promise across a spectrum of endpoints, including, behavior, seizure reduction and sleep. The data are from two open-label...

Consortium Advances Behavioral Insights and Diverse Patient Perspectives Across Product Development Lifecycle MORRISVILLE, N.C., June 03, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today launched its Patient Voice Consortium. The Consortium is a cross-functional hub designed to share expertise, resources and relationships to ensure early and strategic integration of patient perspectives across the product lifecycle. Tapping Syneos Health clinical and commercial minds, the Consortium combines therapeutic, patient reported outcomes and registries, patient advocacy, storytelling, behavioral science, compliance and health policy capabilities to put patient perspectives at the forefront of innovation. The recognition of “patient voice” as an essential element...

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of June 3, 2021.MCLEAN, Va., June 03, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) averaged 2.99 percent. “Home prices continue to accelerate while inventory remains low and new home construction cannot happen fast enough,” said Sam Khater, Freddie Mac’s Chief Economist. “There are many potential homebuyers who would like to take advantage of low mortgage rates, but competition is strong. For homeowners however, continued low rates make refinancing an option worth considering.” News Facts30-year fixed-rate mortgage averaged 2.99 percent with an average 0.6 point for the week ending June 3, 2021, up from last week...

Chicago IL, June 03, 2021 (GLOBE NEWSWIRE) — FOMO CORP. (https://www.fomoworldwide.com – US OTC: FOMC) is pleased to announce that its acquisition target, SmartGuard-Solutions LLC (SGS-https://www.smartguard-solutions.com) has entered into a strategic, revenue sharing alliance with GNW Technologies LLC (dba Cyberclean Systems) of North Chesterfield, Virginia (Cyberclean- https://cybercleansystems.com) to jointly market and finance SGS’s air disinfecting, UV-C light fan. Cyberclean is a technology-focused company and is a pioneer in the integration of autonomous mobile robots in the workplace with more than 1,000 robotic deployments for major companies in 2020. It has a diverse group of clients which includes, among others, large hospitals, universities, schools, and property management companies. At the onset of the COVID-19...

CHARLOTTESVILLE, Va., June 03, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it has completed the $2,100,000 private placement of 700,001 shares of common stock at a price of $3.00 per share (the “Shares”) on June 1, 2021. The private placement investors included Bespoke Growth Partners, Inc., a company controlled by a member of management, a member of the Board of Directors of the Company, and Keystone Capital Partners, LLC. No warrants were issued and no brokers fees were incurred in this financing transaction. As previously disclosed, the Company received $291,003 upon the parties’ execution of their respective...